Ameriprise’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,891
| Closed | -$282K | – | 4038 |
|
|
2022
Q4 | $282K | Sell |
6,891
-51,419
| -88% | -$2.1M | ﹤0.01% | 3605 |
|
|
2022
Q3 | $2.34M | Sell |
58,310
-36,240
| -38% | -$1.46M | ﹤0.01% | 2714 |
|
|
2022
Q2 | $3.32M | Buy |
+94,550
| New | +$3.32M | ﹤0.01% | 2557 |
|
|
2021
Q2 | – | Sell |
-34,888
| Closed | -$1.76M | – | 3965 |
|
|
2021
Q1 | $1.76M | Buy |
34,888
+3,911
| +13% | +$197K | ﹤0.01% | 2906 |
|
|
2020
Q4 | $1.61M | Sell |
30,977
-14,047
| -31% | -$731K | ﹤0.01% | 2884 |
|
|
2020
Q3 | $1.96M | Buy |
45,024
+12,362
| +38% | +$538K | ﹤0.01% | 2680 |
|
|
2020
Q2 | $1.4M | Buy |
+32,662
| New | +$1.4M | ﹤0.01% | 2769 |
|
|
2018
Q4 | – | Sell |
-4,187
| Closed | -$203K | – | 3767 |
|
|
2018
Q3 | $203K | Buy |
+4,187
| New | +$203K | ﹤0.01% | 3539 |
|
|
2015
Q1 | – | Sell |
-7,188
| Closed | -$388K | – | 3851 |
|
|
2014
Q4 | $388K | Buy |
7,188
+5,836
| +432% | +$315K | ﹤0.01% | 3219 |
|
|
2014
Q3 | $70K | Sell |
1,352
-112
| -8% | -$5.8K | ﹤0.01% | 3842 |
|
|
2014
Q2 | $76K | Sell |
1,464
-2,668
| -65% | -$139K | ﹤0.01% | 3714 |
|
|
2014
Q1 | $193K | Buy |
4,132
+2,130
| +106% | +$99.5K | ﹤0.01% | 3255 |
|
|
2013
Q4 | $88K | Sell |
2,002
-140
| -7% | -$6.15K | ﹤0.01% | 3436 |
|
|
2013
Q3 | $82K | Buy |
2,142
+1,546
| +259% | +$59.2K | ﹤0.01% | 3551 |
|
|
2013
Q2 | $21K | Buy |
+596
| New | +$21K | ﹤0.01% | 4251 |
|